Back
ADMA Biologics Vs. Nebius Group NV Industry Stock Comparison
Buy
57
ADMA
ADMA Biologics
Last Price:
$18.37
Seasonality Move:
8.6%
Sell
48
NBIS
Nebius Group NV
Last Price:
$46.08
Seasonality Move:
0.69%
Buy
57
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy, Sell or Hold?
-
The current ADMA Biologics [ADMA] share price is $17.81. The Score for ADMA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
ADMA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Nebius Group NV (NBIS)
is a Sell
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $47.10. The Score for NBIS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADMA Stock Price Chart
What is ADMA Biologics's stock price today?
-
The ADMA Biologics share price today is $17.81Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADMA is experiencing slight selling pressure.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $47.10Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIS is experiencing selling pressure, which indicates risk of future bearish movement.
ADMA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 38.16 | Sell |
Chaikin Money Flow: | -399332 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.84 - 20.64) | Sell |
Bollinger Bands (100): | (17.23 - 21.51) | Sell |
NBIS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.76 | Buy |
Relative Strength Index (14 RSI): | 50.79 | Buy |
Chaikin Money Flow: | -4446199 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.8 - 52.82) | Sell |
Bollinger Bands (100): | (23.8 - 44.96) | Buy |
ADMA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.1 | Sell |
20-day SMA: | 18.96 | Sell |
50-day SMA: | 20.25 | Sell |
200-day SMA: | 18.9 | Sell |
8-day EMA: | 18.09 | Sell |
20-day EMA: | 18.69 | Sell |
50-day EMA: | 19.41 | Sell |
200-day EMA: | 17.94 | Sell |
NBIS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.66 | Sell |
20-day SMA: | 50.02 | Sell |
50-day SMA: | 40.18 | Buy |
200-day SMA: | 29.92 | Buy |
8-day EMA: | 10.47 | Buy |
20-day EMA: | 4.49 | Buy |
50-day EMA: | 1.85 | Buy |
200-day EMA: | 0.47 | Buy |
ADMA Biologics Earnings Growth & ADMA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.34 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.29 per share, and a decrease next year of $0.16 per share.
ADMA Biologics Technical Analysis
Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nebius Group NV Technical Analysis
Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |